DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Borges VF, Ferrario C, Aucoin N. et al.
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2 / HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
JAMA oncology 2018;
DOI: 10.1001/jamaoncol.2018.1812.
We do not assume any responsibility for the contents of the web pages of other providers.